PAVmed Inc. Share Price & Technical Analysis
PAVM · $6.39 (+0.63%)
Healthcare / Medical Devices
$6.39
+0.63%
PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing …
Price chart
Seasonality
May has 0 positive and 5 negative years (last 5 years shown)
-23% return in May, -20% avg return in past 3 year May month.
8% return in 2026, -101% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 24% | 22% | 3% | -18% | -23% | – | – | – | – | – | – | – | 8% |
| 25 | 6% | 14% | -1% | 1% | -22% | 2% | -2% | -15% | -13% | -7% | -13% | -43% | -94% |
| 24 | -45% | 13% | -22% | -7% | -33% | -44% | 6% | 7% | 32% | -13% | -8% | -34% | -148% |
| 23 | -2% | -7% | -20% | 10% | -7% | 2% | -8% | -16% | -8% | -13% | 18% | -11% | -62% |
| 22 | -30% | -13% | -14% | -5% | -20% | -9% | 30% | -2% | -27% | 37% | -44% | -31% | -128% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
PAVmed Inc. engages in acquiring, developing, and commercializing novel products that target unmet needs in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; EsoCheck Esophageal Cell Collection Device, which consists of diagnostic test that serves as a testing tool for preventing esophageal adenocarcinoma deaths, through early detection of esophageal precancer in at-risk gastroesophageal reflux disease, including chronic heartburn and acid reflux or simply reflux in patients; and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay performed on surface esophageal cells collected with EsoCheck device. Its product pipeline also comprises EsoCure Esophageal Ablation Device for treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$45.53M
P/E ratio
—
52W high
$28.44
52W low
$6.00
Volume
6,460
Beta
0.64
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is PAVmed Inc. share price today?
- PAVmed Inc. (PAVM) last traded around $6.39 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does PAVM have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for PAVM. Download the app for real-time alerts.
- How can I analyze PAVmed Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.